Activating KIR molecules and their cognate ligands prevail in children with a diagnosis of ASD and in their mothers

Brain, Behavior, and Immunity

Volumn 36, Issue , 2014, Pages 54-60

  Guerini, Franca R ^a   Bolognesi, Elisabetta ^a   Chiappedi, Matteo ^b   Manca, Salvatorica ^c   Ghezzo, Alessandro ^d   Agliardi, Cristina ^a   Zanette, Michela ^a   Littera, Roberto ^e   Carcassi, Carlo ^e,f   Sotgiu, Stefano ^g   Clerici, Mario ^a,h  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^c Neurology Unit   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e Binaghi Hospital   (Italy)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g UNIVERSITY OF SASSARI   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

Author keywords

Autism; HLA ligands; Human leukocyte antigens; Killer cell immunoglobulin like receptor; Kir genes; Maternal immunity; Natural killer cells

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ARTICLE; AUTISM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; KARYOTYPE; KILLER CELL; MAJOR CLINICAL STUDY; MALE; NERVE CELL PLASTICITY; PRIORITY JOURNAL; TROPHOBLAST;

AUTISM; HLA LIGANDS; HUMAN LEUKOCYTE ANTIGENS; KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR; KIR GENES; MATERNAL IMMUNITY; NATURAL KILLER CELLS;

CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; HLA ANTIGENS; HUMANS; LIGANDS; MALE; MOTHERS; RECEPTORS, KIR;

EID: 84891826729     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.10.006     Document Type: Article

References (43)

1. Altevogt B.M., Hanson S.L., Leshner A.I. Autism and the environment: challenges and opportunities for research. Pediatrics 2008, 121:1225-1229.
2. Amaral D.G., Schumann C.M., Nordahl C.W. Neuroanatomy of autism. Trends Neurosci. 2008, 31:137-145. (Review).
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. fourth ed.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders Fifth Edition of the (DSM-5) 2013, American Psychiatric Publishing.
5. Ashwood P., Krakowiak P., Hertz-Picciotto I., Pessah I.N., Van de Water J. Altered T cell responses in children with autism. Brain Behav. Immun. 2010, 25:840-849.
6. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 2011, 25:40-45.
7. Atladóttir H.O., Pedersen M.G., Thorsen P., Mortensen P.B., Deleuran B., Eaton W.W., et al. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 2009, 124:687-694.
8. Braunschweig D., Van de Water J. Maternal autoantibodies in autism. Arch. Neurol. 2012, 69:693-699. (Review). 10.1001/archneurol.2011.2506.
9. Bressler J.P., Gillin P.K., O'Driscoll C., Kiihl S., Solomon M., Zimmerman A.W. Maternal antibody reactivity to lymphocytes of offspring with autism. Pediatr. Neurol. 2012, 47:337-340. 10.1016/j.pediatrneurol.2012.06.017.
10. Carr W.H., Pando M.J., Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 2005, 175:5222-5229.
11. Cella M., Longo A., Ferrara G.B., Strominger J.L., Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J. Exp. Med. 1994, 180:1235-1242.
12. Comi A.M., Zimmerman A.W., Frye V.H., Law P.A., Peeden J.N. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 1999, 14:388-394.
13. Croen L.A., Grether J.K., Yoshida C.K., Odouli R., van de Water J.V. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch. Pediatr. Adolesc. Med. 2005, 159:151-157.
14. Croen L.A., Braunschweig D., Haapanen L., Yoshida C.K., Fireman B., Grether J.K., et al. Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol. Psychiatry 2008, 64:583-588.
15. Enstrom A.M., Lit L., Onore C.E., Gregg J.P., Hansen R.L., Pessah I.N., et al. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav. Immun. 2009, 23:24-33.
16. Fusco C., Guerini F.R., Nocera G., Ventrella G., Caputo D., Valentino M.A., et al. KIRs and their HL Aligands in remitting-relapsing multiple sclerosis. J. Neuroimmunol. 2010, 15:232-237.
17. Garty B.Z., Ludomirsky A., Danon Y.L., Peter J.B., Douglas S.D. Placental transfer of immunoglobulin G subclasses. Clin. Diagn. Lab. Immunol. 1994, 1:667-669.
18. Gesundheit B., Rosenzweig J.P., Naor D., Lerer B., Zachor D.A., Procházka V., et al. Immunological and autoimmune considerations of Autism Spectrum Disorders. J. Autoimmun. 2013, 44:1-7. (Review).
19. Guerini F.R., Clerici M. NK cells in human disease: an evolving story. Clin. Immunol. 2012, 143:203-206.
20. Guerini F.R., Bolognesi E., Chiappedi M., De Silvestri A., Ghezzo A., Zanette M., et al. HLA polymorphisms in Italian children with autism spectrum disorders: results of a family based linkage study. J. Neuroimmunol. 2011, 230:135-142.
21. + complex in HIV exposed seronegative individuals. J. Infect. Dis. 2011, 203:1235-1239.
22. Guerini F.R., Mancuso R., Agostini S., Agliardi C., Zanzottera M., Hernis A., et al. Activating KIR/HLA complexes in classic Kaposi's Sarcoma. Infect. Agent Cancer 2012, 2:7-9.
23. Gumperz J.E., Barber L.D., Valiante N.M., Percival L., Phillips J.H., Lanier L.L., et al. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J. Immunol. 1997, 158:5237-5241.
24. Kulkarni S., Martin M.P., Carrington M. The Yin and Yang of HLA and KIR in human disease. Semin. Immunol. 2008, 20:343-352.
25. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 2005, 23:225-274.
26. Lauritsen M.B., Pedersen C.B., Mortensen P.B. Effects of familial risk factors and place of birth on the risk of autism: a nationwide register-based study. J. Child Psychol. Psychiatry 2005, 46:963-971.
27. Martin M.P., Gao X., Lee J.H., Nelson R., Detels J.J., Goedert S., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 2002, 31:429-434.
28. Middleton D., Gonzelez F. The extensive polymorphism of KIR genes. Immunology 2010, 129:8-19.
29. Middleton D., Williams F., Halfpenny I.A. KIR genes. Transpl. Immunol. 2005, 14:135-142.
30. Muhle R., Trentacoste S.V., Rapin I. The genetics of autism. Pediatrics 2004, 113:472-486. (Review).
31. Saresella M., Marventano I., Guerini F.R., Mancuso R., Ceresa L., Zanzottera M., Rusconi B., Maggioni E., Tinelli C., Clerici M. An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol. Psychiatry 2009, 66:978-984. 10.1016/j.biopsych.2009.06.020.
32. Shiina T., Hosomichi K., Inoko H., Kulski J.K. The HLA genomic loci map: expression, interaction, diversity and disease. J. Hum. Genet. 2009, 54:15-39.
33. Singer H.S., Morris C.M., Gause C.D., Gillin P.K., Crawford S., Zimmerman A.W. Antibodies against fetal brain in sera of mothers with autistic children. J. Neuroimmunol. 2008, 194:165-172.
34. Singer H.S., Morris C., Gause C., Pollard M., Zimmerman A.W., Pletnikov M. Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: a pregnant dam mouse model. J. Neuroimmunol. 2009, 211:39-48. 10.1016/j.jneuroim.2009.03.011.
35. Singh V.K., Warren R.P., Odell J.D., Warren W.L., Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav. Immun. 1993, 7:97-103.
36. Soria A., Guerini F.R., Bandera A., Bolognesi E., Uglietti A., Fusco C., et al. KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy. PLoS One 2011, 6:e27349.
37. Sweeten T.L., Posey D.J., McDougle C.J. High blood monocyte counts and neopterin levels in children with autistic disorder. Am. J. Psychiatry 2003, 160:1691-1693.
38. Torres A.R., Maciulis A., Stubbs E.G., Cutler A., Odell D. The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Hum. Immunol. 2002, 63:311-316.
39. Torres A.R., Sweeten T.L., Cutler A., Bedke B.J., Fillmore M., Stubbs E.G., Odell D. The association and linkage of the HLA-A2 class I allele with autism. Hum. Immunol. 2006, 67:346-351.
40. Torres A.R., Westover J.B., Gibbons C., Johnson R.C., Ward D.C. Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism. Brain Behav. Immun. 2012, 26:1122-1127. 10.1016/j.bbi.2012.07.014.
41. Vojdani A., Mumper E., Granpeesheh D., Mielke L., Traver D., et al. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J. Neuroimmunol. 2008, 205:148-154.
42. Warren R.P., Foster A., Margaretten N.C. Reduced natural killer cell activity in autism. J. Am. Acad. Child Adolesc. Psychiatry 1987, 26:333-335.
43. Westover, J.B., Sweeten, T.L., Benson, M., Bray-Ward, P., Torres, A.R., 2011. Immune dysfunction in autism spectrum disorder. In: Valsamma Eapen (Ed.), Autism - A Neurodevelopmental Journey from Genes to Behaviour. InTech. Available from: http://www.intechopen.com/articles/show/title/immune-dysfunction-inautism-spectrum-disorder.